إعلان
إعلان
ANIP
ANI Pharmaceuticals, Inc.
76.24
USDبرعاية
-4.80
-5.92%
٠٩ يناير, ١٥:٥٩ UTC -5
مغلق
بعد الإغلاق
76.94
+0.70
+0.92%
تقارير أرباح ANIP
النسبة الإيجابية المفاجئة
ANIP تفوق 26 من 40 آخر التقديرات.
65%
التقرير التالي
بيانات التقرير القادم
٢٦ فبراير ٢٠٢٦
Estimate for Q4 25 (Revenue/ EPS)
$237.82M
/$2.07
التغير الضمني من Q3 25 (Revenue/ EPS)
+4.39%
/+1.47%
التغير الضمني من Q4 24 (Revenue/ EPS)
+24.79%
/+26.99%
ANI Pharmaceuticals, Inc. earnings per share and revenue
On ٠٧ نوفمبر ٢٠٢٥, ANIP reported earnings of 2.04 USD per share (EPS) for Q3 25, beating the estimate of 1.78 USD, resulting in a 14.04% surprise. Revenue reached 227.81 مليون, compared to an expected 215.26 مليون, with a 5.83% difference. The market reacted with a +0.22% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 10 المحللين forecast an EPS of 2.07 USD, with revenue projected to reach 237.82 مليون USD, implying an زيادة of 1.47% EPS, and زيادة of 4.39% in Revenue from the last quarter.
الأسئلة الشائعة
What were ANI Pharmaceuticals, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, ANI Pharmaceuticals, Inc. reported EPS of $2.04, beating estimates by 14.04%, and revenue of $227.81M, 5.83% above expectations.
How did the market react to ANI Pharmaceuticals, Inc.'s Q3 2025 earnings?
The stock price moved up 0.22%, changed from $90.23 before the earnings release to $90.43 the day after.
When is ANI Pharmaceuticals, Inc. expected to report next?
The next earning report is scheduled for ٢٦ فبراير ٢٠٢٦.
What are the forecasts for ANI Pharmaceuticals, Inc.'s next earnings report?
Based on 10
المحللين, ANI Pharmaceuticals, Inc. is expected to report EPS of $2.07 and revenue of $237.82M for Q4 2025.
Which companies are reporting earnings today?
شيك FXEmpire's Earnings Calendar for today's list of reporting companies.
إعلان